Last reviewed · How we verify
NCT03084406: CV-ATOD
Efficacy of Centervention-ATOD: An Implementation Tool for Dissemination of Evidence-based Programs for Substance Abuse
NA trial testing Centervention-ATOD (CV-ATOD) in Substance Abuse in 327 participants. Completed in 22 December 2017.
22 December 2017
Quick facts
| Lead sponsor | 3-C Institute for Social Development |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 327 |
| Start date | 13 February 2017 |
| Primary completion | 22 December 2017 |
| Estimated completion | 22 December 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Centervention-ATOD (CV-ATOD)
Conditions studied
- Substance Abuse — all drugs for Substance Abuse →
Sponsor
3-C Institute for Social Development
Who can join
Adults 11 to 65, any sex, with Substance Abuse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The pilot test of Centervention-ATOD, a customizable suite of online tools specifically designed to support quality implementation and sustainability of any ATOD-EBP within real-world service settings, will evaluate whether the product awards additive benefits in provider implementation proficiency and efficacy, quality of implementation delivery, and EBP (i.e., Free Talk or CHOICE) outcomes compared to traditional implementation methods. Additionally, a cost-effectiveness study will be conducted to assess whether the implementation support strategy (i.e., Centervention-ATOD) is more cost-effective than traditional implementation methods.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03084406
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Substance Abuse
Currently open trials in the same condition.
- NCT06627764 — SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families · NA · recruiting
- NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
- NCT06880705 — The Trans-Led Care Study · NA · recruiting
- NCT06852170 — Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev · NA · recruiting
- NCT05776316 — Harm Reduction Services · NA · recruiting
Other 3-C Institute for Social Development trials
Trials by the same sponsor.
- NCT07300930 — A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination · NA · not yet recruiting
- NCT06728800 — Leveraging Interactive Digital Technology to Increase Access to Family-Based Behavioral Treatment for Childhood Obesity · NA · not yet recruiting
- NCT06728683 — Assist MH Digital Technologies to Support School Mental Health Care · NA · completed
- NCT06213142 — Developing the Unified Protocol-Single Session Experience Platform for Adolescent Mental Health · NA · completed
- NCT05743712 — Pilot Test of a Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03084406 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by 3-C Institute for Social Development
- Last refreshed: 1 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03084406.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing